Apriss logo

Vermont Adopts Appriss' Platform to Mitigate Drug Diversion

Print
| Source: Appriss

LOUISVILLE, Ky., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that the state of Vermont has adopted Appriss' Prescription Drug Monitoring Solution to improve patient safety and help deter prescription drug abuse and drug diversion.

Prescription Monitoring Programs (PMPs) are state-run programs that track the distribution of narcotics and other prescriptions for federally controlled substances. Appriss's PMP platform provides access to mandatory pharmacy reporting and offers secure accessibility to data across state lines.

"Appriss is committed to ensuring patient safety," says Krishnan Sastry, Executive Vice President of Appriss, Inc.    "Appriss's solution will support providers and dispensers in Vermont to ensure better prescribing decisions and help state administrators analyze patterns of consumption to drive patient safety and health policy."

Vermont implemented the PMP platform in October and joins 23 other states in choosing Appriss' PMP Solution to address prescription drug abuse and diversion.

About Appriss

Appriss provides data-driven solutions to fulfill our mission of keeping communities safe and informed.  Partnering with public safety, healthcare, and leading private and public companies, Appriss delivers solutions that prevent fraud, mitigate risk, fight crime, ensure compliance, increase public safety and save lives.  Appriss' solutions are always backed by excellent customer support with technical agents in the US that are available to help 24x7x365.

For more information, visit www.appriss.com (http://www.appriss.com).

Kathy Sue Bennett
Marketing Manager